FDA recall record

Acella Pharmaceuticals Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pads, Net weight 3.7g recall — FDA D-0074-2023

Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.

Class IIIclassification
D-0074-2023official record ID
Dec 7, 2022report date

Recall record at a glance

Official recordD-0074-2023
CategoryDrug Recalls
ClassificationClass III
FDA record statusTerminated
Recalling firmAcella Pharmaceuticals, LLC
Report dateDec 7, 2022
Recall initiation dateNov 14, 2022
Quantity528 cartons
LocationAlpharetta, GA, United States

Official product description

Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pads, Net weight 3.7g (60 cleansing pads Net weight 3.7 g each per carton,) Rx Only, Manufactured For: Acella Pharmaceuticals, LLC Alpharetta, GA 300025, NDC 42192-113-60

Why the product was recalled

Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.

Distribution information

USA Nationwide

How to read the classification

FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.